Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Invested Capital (2018 - 2025)

Dna X (SONM) has disclosed Return on Invested Capital for 8 consecutive years, with 31.92% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Invested Capital rose 3272.0% year-over-year to 31.92%, compared with a TTM value of 31.92% through Sep 2025, up 3272.0%, and an annual FY2024 reading of 4.06%, down 406.0% over the prior year.
  • Return on Invested Capital was 31.92% for Q3 2025 at Dna X, up from 25.61% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 31.92% in Q3 2025 and bottomed at 7.82% in Q4 2022.
  • Average Return on Invested Capital over 5 years is 1.79%, with a median of 0.8% recorded in 2024.
  • The sharpest move saw Return on Invested Capital plummeted -701bps in 2024, then surged 3272bps in 2025.
  • Year by year, Return on Invested Capital stood at 2.42% in 2021, then tumbled by -224bps to 7.82% in 2022, then surged by 100bps to 0.01% in 2023, then plummeted by -98182bps to 7.02% in 2024, then skyrocketed by 555bps to 31.92% in 2025.
  • Business Quant data shows Return on Invested Capital for SONM at 31.92% in Q3 2025, 25.61% in Q2 2025, and 9.01% in Q1 2025.